The Grey Areas of G&E, Donations, Sponsorship and Hospitality in High-Risk Markets: What Companies are Now Doing to Strengthen Risk Monitoring Around Compliant HCP Relations

May 10, 2024 1:45pm

Jason Cofield
Vice President & Compliance Officer
Foundation Medicine

Andrew Cliver
Head of Compliance, North America
Siemens Healthineers

Tatiana Martins
Partner
Davis Polk & Wardwell LLP

Topics will include:

  • When donations can cross the FCPA line
  • Responding to scrutiny over improper influence of healthcare providers through travel, gifts, entertainment — particularly in sponsorship of educational meetings and conferences
  • When it is appropriate to retain a foreign healthcare provider for advisory services and compensate for their time
  • Virtual calls, mobile app meetings and their associated compliance risks, as well as the value of engaging HCPs on the virtual stage
  • Using HCPs as social media influencers
  • Sending HCPs to industry conferences
  • What level of due diligence is now required before outreach to an HCP?
  • How companies are operationalizing controls around HCP conflicts of interest